Medical/Pharmaceuticals

Alphamab Oncology Announced Anti-HER2 Bispecific ADC JSKN003 Received Approval from CDE to Initiate a Phase III Clinical Study for Ovarian Cancer

SUZHOU, China, Dec. 27, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 has received approval from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) to initiate a Phase...

2024-12-30 13:28 6783

"Closing the Women's Health Gap - Highlights of Biotropics Malaysia clinical study by Women, on Women, for Women"

SHAH ALAM, Malaysia, Dec. 30, 2024 /PRNewswire/ -- While gender parity has seen progress in recent years, the women's health gap remains significant. Women, despite comprising half of the global labor force[1], often face under-diagnosis and under-representation in healthcare research. Biotropics...

2024-12-30 10:00 4442

Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging

MELBOURNE, Australia and INDIANAPOLIS, Dec. 30, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) today announces that it has submitted its Biologics License Application (BLA) tothe United States (U.S.) Food and Drug Administration (FDA) for TLX250-CDx...

2024-12-30 06:00 3858

Ascentage Pharma to Present at 43rd Annual J.P. Morgan Healthcare Conference

ROCKVILLE, Md. and SUZHOU, China, Dec. 27, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that its Chairman and ...

2024-12-27 09:44 13432

VISTA Eye Specialist Revolutionizes Dry Eye Treatment with Groundbreaking Research and Advanced Technology

PETALING JAYA, Malaysia, Dec. 27, 2024 /PRNewswire/ -- VISTA Eye Specialist (VISTA),Malaysia's leading eye care provider, proudly announces a major milestone in the treatment of dry eye disease. A groundbreaking study led by Dr. Aloysius Joseph Low, Medical Director and Ms. Azarina Abdullah, Optom...

2024-12-27 08:00 4557

Microtech Announces First Human Case of Implantable Microsensor for Heart Failure

TEL AVIV, Israel, Dec. 26, 2024 /PRNewswire/ -- Microtech, a wholly owned subsidiary of Medinol Inc., a leader in global MedTech research and development, announced that it has initiated human clinical trials of their microsensor platform, in a trial to measure atrial pressures important for the ...

2024-12-26 19:00 4785

IND Application for a Phase I/II Clinical Study of Anti-HER2 Bispecific ADC Subcutaneous Co-formulation JSKN033 was Approved

SUZHOU, China, Dec. 26, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that a phase I/II clinical trial (Study ID: JSKN033-102) of JSKN033, a high-concentration subcutaneous co-formulation consisting of anti-HER2 bispecific antibody-drug conjugate (ADC) and PD-L1 immune ch...

2024-12-26 17:09 5697

Industry Partnership | Basecare Medical Group (2170.HK) and Jinghua Medical Group Sign Strategic Cooperation Agreement

SUZHOU, China, Dec. 25, 2024 /PRNewswire/ -- On December 24, 2024, Basecare Medical Group (2170.HK) held a strategic cooperation signing ceremony with Jinghua Medical Group inShenyang. Basecare Medical possesses a comprehensive technological platform covering andrology, embryo culture, genetics, ...

2024-12-25 11:03 7978

European Wellness Biomedical Group Announces New Klotho Research Initiative Led by Prof. Mike Chan

HEIDELBERG, Germany, Dec. 25, 2024 /PRNewswire/ -- European Wellness Biomedical Group (EWBG) has launched a new research initiative focused onKlotho , a protein with transformative potential inlon...

2024-12-25 09:00 8345

Designs For Health Inc. Held Liable For Infringement of Kaneka's Ubiquinol Patent

TOKYO, Dec. 25, 2024 /PRNewswire/ -- Kaneka has successfully defended its patent for stabilizing Ubiquinol. OnDecember 20, 2024, Kaneka Corporation won its lawsuit against Designs for Health, Inc. and AmericanRiver Nutrition, LLC for infringement of Kaneka's U.S. Patent No. 7,829,080 (the "'080 P...

2024-12-25 02:31 6581

One More Certificate: Syrebo Hand Rehabilitation Robot Achieves TGA Certification in Australia

SHANGHAI, Dec. 24, 2024 /PRNewswire/ -- Syrebo, a global leader in rehabilitation robotics, is proud to announce that its Hand Rehabilitation Robot has been granted official certification by the Therapeutic Goods Administration (TGA), marking a significant achievement in the company's mission to...

2024-12-24 15:38 5384

Inauguration of MRI Facility and Health Service Initiative at Bhayangkara Kediri Hospital, Featuring DNA Testing Services in Collaboration with Regene Genomics

JAKARTA and KEDIRI, Indonesia, Dec. 24, 2024 /PRNewswire/ -- Bhayangkara Kediri Hospital inaugurated its new MRI service building and laid the cornerstone for a new service facility, marking a significant step forward in enhancing healthcare services in Kediri and surrounding areas.

2024-12-24 12:38 3514

Kickstart 2025 with Expert Holiday Health Tips

KUALA LUMPUR, Malaysia, Dec. 23, 2024 /PRNewswire/ -- As Pantai Hospital Kuala Lumpur (PHKL) celebrates 50 years of excellence in patient care, it's a moment to reflect on how small, proactive steps can make a significant difference to your health. The holiday season is a time of joy, but it also...

2024-12-23 15:21 5460

SCG Cell Therapy partners A*STAR to accelerate RNA-based therapeutic development in Singapore

* SCG Cell Therapy signed a Memorandum of Understanding (MoU) with A*STAR Bioprocessing Technology Institute (A*STAR BTI) and Nucleic Acid Therapeutics Initiative (NATi) to advance ribonucleic acid (RNA)-based therapeutic manufacturing process development and clinical translation. * The parti...

2024-12-23 09:00 4312

Macrogen Consortium win tender for National Bio Big Data Project

Illumina is proud to be selected as sequencing technology partner to the Macrogen Consortium. SEOUL, South Korea, Dec. 23, 2024 /PRNewswire/ -- Macrogen a global healthcare company that specializes in precision medicine and Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and arra...

2024-12-23 08:00 4240

Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards

Commercial validation in Europe parallels ongoing RESPONDER-HF clinical trial TEWKSBURY, Mass., Dec. 21, 2024 /PRNewswire/ -- Corvia Medical, Inc., a company dedicated to transforming the treatment of heart failure, announced today that it has achieved CE certification for the Corvia® Atrial Shun...

2024-12-21 04:03 3469

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

SAN FRANCISCO and SUZHOU, China, Dec. 20, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune...

2024-12-20 20:20 7960

CNN explores the fascinating science of sweat - On Vital Signs

HONG KONG, Dec. 20, 2024 /PRNewswire/ -- With rapid advancements in sweat diagnostics, CNN's Chief Medical Correspondent, Dr. Sanjay Gupta , explores how one of the body's most overlooked fluids has the potential to transform healthcare...

2024-12-20 13:16 3494

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation Announce $11M Investment to Advance PMB-CT01 (BAFF-R CAR T cell therapy) for Relapsed/Refractory Follicular Lymphoma

* Based on promising early clinical results from PeproMene Bio's PMB-102 Phase 1 study, they will receive$6M USD upfront plus an additional $5M USD in conditional tranched investments from the Institute for Follicular Lymphoma Innovation. * Patients with relapsed/refractory follicular lympho...

2024-12-19 23:00 4031

Prenetics' IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements

Collaboration to Focus on Nutrition, Cellular Rejuvenation, Protein, Collagen and Overall Wellness IM8, a New Premium Supplements Brand, Launched Officially on November 18th on IM8health.com CHARLOTTE, N.C., Dec. 19, 2024 /PRNewswire/ -- Prenetics' (NASDAQ:PRE) IM8, a...

2024-12-19 21:30 4212
1 ... 127128129130131132133 ... 381